Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2007

Jaggi JS, Carrasquillo JA, Seshan SV, Zanzonico P, Henke E, Nagel A, et al. Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor. J Clin Invest. 2007;117(9):2422-30.

Adkins MW, Williams SK, Linger J, Tyler JK. Chromatin disassembly from the PHO5 promoter is essential for the recruitment of the general transcription machinery and coactivators. Mol Cell Biol. 2007;27(18):6372-82.

Magro CM, A Crowson N. So called 'de novo intraepidermal epithelioid melanocytic dysplasia' is melanoma in situ. J Cutan Pathol. 2007;34(10):812.

Hoda SA, Rosen PP. Contemporaneous H&E sections should be standard practice in diagnostic immunopathology. Am J Surg Pathol. 2007;31(10):1627.

Neto AG, Dainiak C, Qin L, Salem RR, Jain D. Intraductal papillary cholangiocarcinoma associated with von Meyenberg complexes: a case report. Dig Dis Sci. 2007;52(10):2643-5.

Signoretti S, Loda M. Prostate stem cells: from development to cancer. Semin Cancer Biol. 2007;17(3):219-24.

Magro CM, Weinerman DJ, Porcu PL, Morrison CD. Post-transplant EBV-negative anaplastic large-cell lymphoma with dual rearrangement: a propos of two cases and review of the literature. J Cutan Pathol. 2007;34 Suppl 1:1-8.

Hristov AC, Young RH, Vang R, Yemelyanova AV, Seidman JD, Ronnett BM. Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: a report of 30 cases. Am J Surg Pathol. 2007;31(10):1502-11.

Skoura A, Sanchez T, Claffey K, Mandala SM, Proia RL, Hla T. Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest. 2007;117(9):2506-16.

Mones JV, Coleman M, Kostakoglu L, Furman RR, Chadburn A, Shore TB, et al. Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement. Leuk Lymphoma. 2007;48(2):342-8.